You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 7,232,572


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,232,572
Title:Methods of treating rosacea
Abstract:A method of treating rosacea in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat rosacea, but has substantially no antibiotic activity.
Inventor(s): Ashley; Robert A. (Tucson, AZ)
Assignee: CollaGenex Pharmaceuticals, Inc. (Newtown, PA)
Application Number:11/061,866
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 7,232,572
Patent Claim Types:
see list of patent claims
Use;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 7,232,572: A Detailed Analysis

Introduction

Patent 7,232,572, like any other patent, is a complex document that outlines the intellectual property rights of an invention. To fully comprehend its significance, it is crucial to delve into the patent's scope, claims, and the broader patent landscape.

Patent Overview

Patent Number and Title

The United States Patent 7,232,572 is a utility patent that was granted to protect a specific invention. While the exact title and inventors are not provided here, understanding the general context of such patents is essential.

Filing and Grant Dates

Patents typically have a filing date and a grant date. The filing date marks when the patent application was submitted, and the grant date is when the patent was officially approved. For Patent 7,232,572, these dates would be critical in determining its priority and the timeline of its protection[4].

Patent Scope

Definition of Patent Scope

Patent scope refers to the breadth and depth of protection granted by the patent. It is a critical aspect in determining what is covered by the patent and what is not. The scope is often debated in terms of patent quality, with narrower claims generally associated with higher grant probabilities and shorter examination processes[3].

Metrics for Measuring Patent Scope

Two key metrics for measuring patent scope are independent claim length and independent claim count. These metrics help in assessing the breadth of the patent claims. Narrower claims, indicated by shorter independent claim lengths and fewer independent claims, are often more specific and less likely to be challenged for being overly broad[3].

Patent Claims

Types of Claims

Patent claims are the heart of a patent, defining what is protected. There are two main types of claims: independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Structure

For Patent 7,232,572, the claim structure would include a set of independent claims that outline the core aspects of the invention. These claims would be followed by dependent claims that provide additional details or limitations. The clarity and specificity of these claims are crucial in defining the patent's scope and validity[3].

Example Claims Analysis

Independent Claims

Independent claims in Patent 7,232,572 would be broad enough to cover the essential features of the invention but specific enough to avoid being overly broad. For instance:

  • Claim 1 might describe the overall system or method of the invention.
  • Claim 20 could describe a specific embodiment or application of the invention.

Dependent Claims

Dependent claims would further refine these independent claims. For example:

  • Claim 2 might describe a specific component of the system outlined in Claim 1.
  • Claim 21 could describe an additional feature or variation of the embodiment in Claim 20.

Patent Landscape

Related Patents and Families

Patent 7,232,572 may be part of a larger patent family, including continuation applications, divisional applications, and continuations-in-part. These related patents can provide a broader view of the inventor's intellectual property strategy and the evolution of the invention over time[1].

Global Dossier and International Filings

Using tools like the Global Dossier, one can identify related applications filed at other intellectual property offices. This helps in understanding the global protection strategy for the invention and potential overlaps or conflicts with other patents[4].

Litigation and Enforcement

Patent Infringement Cases

Patents like 7,232,572 can be involved in litigation, as seen in cases such as Galderma Labs., LP v. Sun Pharm. Indus. Ltd. where multiple patents were alleged to be infringed. Understanding the litigation history can provide insights into the patent's validity and enforceability[2].

Office Actions and Examination History

The examination history, including office actions and responses, can be accessed through tools like the Patent Examination Data System (PEDS) or the Global Dossier. This information can reveal how the patent office interacted with the applicant and any challenges faced during the examination process[4].

Impact on Innovation

Patent Quality and Innovation

The scope and claims of a patent like 7,232,572 can influence innovation. Narrower, clearer claims are generally associated with higher patent quality, which can encourage innovation by providing clear boundaries and reducing litigation costs[3].

Licensing and Collaboration

The clarity and breadth of patent claims can also affect licensing and collaboration. Patents with well-defined claims are more likely to be licensed or used in collaborative agreements, as they provide a clear understanding of what is protected[3].

Key Takeaways

  • Patent Scope: Defined by metrics such as independent claim length and count, which impact the breadth and validity of the patent.
  • Claims Structure: Independent and dependent claims work together to define the invention and its scope.
  • Patent Landscape: Includes related patents, global filings, and litigation history.
  • Innovation Impact: Clear and narrow claims can encourage innovation and facilitate licensing and collaboration.
  • Examination History: Office actions and responses provide insights into the patent's validity and enforceability.

FAQs

What are the key metrics for measuring patent scope?

The key metrics include independent claim length and independent claim count, which help in assessing the breadth and specificity of the patent claims[3].

How do continuation procedures affect patent allowance rates?

Continuation procedures, such as Requests for Continued Examination (RCEs) and continuations-in-part, can affect the allowance rates by allowing applicants to refine their claims and address examiner objections, thereby increasing the chances of patent grant[1].

What is the significance of the Global Dossier in patent searching?

The Global Dossier provides a single portal to access the file histories of related applications from participating IP offices, helping users to see the patent family and related applications, along with dossier, classification, and citation data[4].

How does the clarity of patent claims impact innovation?

Clear and narrow claims are associated with higher patent quality, which can encourage innovation by providing clear boundaries and reducing litigation costs[3].

Where can one find detailed information about a specific patent's examination history?

Detailed information about a patent's examination history can be found using tools like the Patent Examination Data System (PEDS) or the Global Dossier[4].

Sources

  1. Carley, M., & Hegde, D. What Is the Probability of Receiving a US Patent? Emory Law Journal, 58, 101-107.
  2. Galderma Labs., LP v. Sun Pharm. Indus. Ltd. Casetext.
  3. Patent Claims and Patent Scope SSRN.
  4. USPTO - Search for patents USPTO.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,232,572

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 7,232,572

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 330615 ⤷  Subscribe
Australia 2002303250 ⤷  Subscribe
Canada 2440472 ⤷  Subscribe
Canada 2719162 ⤷  Subscribe
Germany 60212613 ⤷  Subscribe
Denmark 1383508 ⤷  Subscribe
European Patent Office 1383508 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.